Menovo(SH:603538) Zheng Quan Zhi Xing·2025-06-11 09:22Core Viewpoint - Ningbo Meinuo Pharmaceutical Co., Ltd. announced the suspension of the conversion of its convertible bonds "Meinuo Convertible Bonds" during the implementation of the 2024 annual equity distribution, along with an adjustment to the conversion price [1][4]. Group 1: Equity Distribution Plan - The company plans to distribute a cash dividend of 0.05 yuan (including tax) per share based on the total share capital of 219,828,267 shares as of May 28, 2025 [2][4]. - The actual results of the equity distribution will be determined based on the calculations by China Securities Depository and Clearing Corporation Limited [2]. - The equity distribution plan has been approved in meetings held on April 17, 2025, and May 8, 2025 [3]. Group 2: Suspension of Conversion - The "Meinuo Convertible Bonds" will stop conversion from June 17, 2025, until the equity distribution registration date, with resumption of conversion on the first trading day after the registration date [4]. - Holders of "Meinuo Convertible Bonds" wishing to enjoy the equity distribution must convert their bonds by June 16, 2025 [4]. Group 3: Communication - The company will disclose the implementation announcement of the 2024 annual equity distribution and the adjustment of the conversion price on June 18, 2025 [4]. - Contact information for the board office is provided for further inquiries [4].